Vipidia bụ ọgwụ e mere maka ọgwụgwọ nke ọrịa shuga nke ụdị na-abụghị insulin.
A na-eji ọgwụ ahụ eme ihe na mmejuputa monotherapy, yana na usoro ọgwụgwọ dị mgbagwoju anya dịka akụkụ nke ọgwụgwọ ọgwụ.
Alogliptin bụ ụdị ọgwụ ọhụụ eji agwọ ọrịa shuga, nke na-abụghị insulin. Ọgwụ ụdị a so na otu ọgwụ a na-akpọ incretinomimetics.
Otu a gụnyere glucagon-yiri glucose na polypeptides insulinotropic. Ngwakọta ndị a na-anabata ịbata mmadụ site na-akpali njikọ nke insulin homonụ.
N'ime otu a, enwere ụdị usoro ọmụmụ abụọ dị na ya:
- Ihe kompeni nwere ihe yiri ihe a na-eme. Ngwakọta kemịkal dị otú ahụ gụnyere liraglutide, exenatide na lixisenatide.
- Ngwakọta ndị na-enwe ike ịgbatị ihe nke incretins na-arụ ọrụ n'ime ahụ. Mgbatị nke ihe ndị a na - eme na - apụta n'ihi mbelata nke mmepụta enzyme pụrụ iche, dipeptidyl peptidase-4, nke na - ebu mbibi nke incretins. Ihe ndị a gụnyere sitagliptin, vildagliptin, saxagliptin, linagliptin na alogliptin.
Alogliptin nwere mmetụta mgbochi inhibitory nhọrọ siri ike na enzyme dipeptidyl peptidase-4 pụrụ iche. Ọdịdị nhọrọ inhibitory na enzyme DPP-4 na alogliptin dị elu ma e jiri ya tụnyere mmetụta yiri ya na enzymes ndị metụtara.
Enwere ike ịchekwa Vipidia ruo afọ atọ. Mgbe oge a gasị, amachibidoro iji ọgwụ eme ihe. Ekwesịrị ịchekwa ebe nchekwa ọgwụ ka ọ ghara ịchapụta ìhè anyanwụ. Ọnọdụ okpomọkụ na ebe nchekwa ekwesịghị ịdị ihe karịrị ogo 25.
Ihe ngosi na contraindications maka ojiji
Vipidia bụ ọgwụ ọgwụ hypoglycemic nke ọgwụ. A na-eji ngwa a na ọgwụgwọ nke ọrịa shuga 2. Ọgwụ a na-arịa ọrịa shuga na-enyere aka melite nchịkwa nke glycemia na plasma ọbara nke onye ọrịa. A na-eji ọgwụ eme ihe mgbe iji usoro ọgwụgwọ nri na mmega ahụ arụ ọrụ adịghị enye nsonaazụ achọrọ.
Enwere ike iji ọgwụ ahụ dị ka naanị akụrụngwa n'oge monotherapy. Na mgbakwunye, enwere ike iji Vipidia jikọta ya na ọgwụ hypoglycemic ndị ọzọ na ọgwụgwọ nke ọrịa shuga ụdị ọrịa shuga nke 2.
Enwere ike iji ọgwụ a na-agwọ ọrịa shuga yana insulin.
Dịka ọgwụ ọ bụla, Vipidia nwere ọtụtụ contraindications na-amachi ị ofụ ọgwụ ahụ. Ihe mgbochi mbu bu dika ndi a:
- ọnụnọ nke ụdị shuga nke 2 na onye ọrịa, hyperensitivity na alogliptin na akụkụ inyeaka nke ọgwụ ahụ;
- onye ọrịa ahụ nwere ọrịa shuga n'ụdị insulin;
- njirimara nke ihe ịrịba ama nke ketoacidosis na-etolite n'ahụ onye ọrịa megide mmalite nke ọrịa shuga;
- njirimara nke nnukwu obi daa;
- ọgba aghara na imeju, nke na-esote mmebi nke arụ ọrụ;
- mmepe nke ọrịa puru iche nke akụrụ, ndị na-esote ihe omume nke ụkọ ọrụ;
- oge ịmụ nwa;
- oge lactation;
- afọ ime dị afọ 18.
Ekwesịrị ịkpachara anya mgbe onye ọrịa nwere ọrịa ọria akwara na oke nha akpata akwara na arụ ọrụ hepatic.
Na mgbakwunye, ekwesịrị ịkpachara anya mgbe ị na-eji ọgwụ ahụ dịka akụrụngwa na usoro ọgwụgwọ siri ike nke ụdị shuga II.
Ntuziaka maka iji ọgwụ ahụ
A na-ewere ọgwụ ọnụ. Ọtụtụ mgbe, usoro ọgwụgwọ ọgwụgwọ akwadoro maka ojiji bụ 25 mg.
Edere ụzọ ka mma ị aụ ọgwụ ọ byụ byụ site n'aka dibia bekee na –echebara nsonaazụ ndị enwetara n'oge nyocha nke ahụ onye ọrịa na njiri mara ya.
A na-a drugụ ọgwụ ahụ otu ugboro n’ụbọchị, a na-a drugụ ọgwụ ahụ n’agbanyeghi usoro nhazi nri. Theụ ọgwụ ahụ bụ ị drinkingụ nnukwu mmiri.
Ojiji nke ogwu nwere ike ime na ihe ndia:
- Dị ka ọgwụ maka monotherapy nke ụdị ọrịa shuga mellitus 2.
- Na mmejuputa iwu-ogwu aghara nke oria, dika akwara dika aru ike di. Enwere ike ị nweta ya na vipidia, metformin, protein sulfonylurea ma ọ bụ insulin.
N'ihe banyere Vipidia na Metformin, a chọghị imeziwanye oke nke ọgwụ ahụ. Imezi dose mgbe ị na-eji ọgwụ ahụ na ọgwụ ndị bụ sọlfọlurea ma ọ bụ insulin.
A na-edozi ọgwụ ahụ iji gbochie mmalite nke hypoglycemic steeti na onye ọrịa nwere ọrịa mellitus.
Ekwesiri iji nlezianya mee ihe mgbe ị na-eji Vipidia na Metformin Teva na thiazolidinedione na ọgwụgwọ ọrịa shuga.
Mgbe akara ngosipụta mbụ nke hypoglycemia pụtara, usoro nke Metformin na thiazolidinedione kwesịrị ibelata.
Mgbe ị na-ewere Vipidia, nsonaazụ ndị a nwere ike ime:
- site na usoro ụjọ ahụ, ihe mere na isi ọwụwa ugboro ugboro;
- site na eriri afọ, ọdịdị nke mgbu n'ime afọ, na-atụba ọdịnaya nke afọ n'ime esophagus, mmepe nke ihe ịrịba ama nke nnukwu pancreatitis;
- site na sistemu ịba ọcha n'anya, omume nke nsogbu na ọrụ nke imeju ga-ekwe omume;
- mmeghachi omume nfụkasị ahụ nwere ike ịda n'ụdị itching, rashes, ede ede Quincke;
- mbufụt nke mualsa nasal na pharynx ga-ekwe omume;
Na mgbakwunye, usoro ahụ ji alụso ọrịa ọgụ nwere ike ibute nsonaazụ dị iche iche, gosipụtara n'ụdị anaphylaxis.
Ọnụ ego nke Vipidia na analogues ya
Ojiji mbadamba ọgwụ Vipidia maka ọrịa shuga na-akacha mma.
Ọ bụrụ na anyị na-ekpebi ọgwụ ahụ site na nyocha ndị mmadụ ji Vipidia hapụ maka ya, anyị nwere ike ikwubi na ọgwụ bụ ọgwụ dị oke mma nke nwere ike ịchịkwa ogo nke glycemia n'ime ahụ mmadụ na-arịa ụdị ọrịa shuga 2.
O bu ogwu eji eme ihe, nke bu nke alogliptin rue ta, na mgbakwunye na Vipidia.
Ọgwụ mepụtara, ihe ndị dị ike dị na ya bụ ihe dịịrị ndị otu ahụ.
Ọgwụ ndị a na-ahụkarị bụ analogues nke Vipidia bụ ndị a:
- Januvia bụ ọgwụ hypoglycemic nke emepụtara na ntọala sitagliptin. Ntọhapụ nke ọgwụ ahụ dị n’ụdị mbadamba ụrọ nke nwere 25, 50 na 100 mg nke ihe mejupụtara. Ihe ngosi ndi eji eme ya bu ihe ndi Vipidia nwere. Enwere ike iji ọgwụ a na monotherapy ma ọ bụ nwee ọgwụgwọ siri ike.
- Yanumet bu nkwadebe siri ike, nke nwere sitagliptin na metformin dika ihe ndi n’aru. Ọgwụ nke akụkụ mbụ dị n'ọrụ bụ 50 mg, yana metformin n'ụdị ọgwụ ahụ nwere ike ịnwe ọnụọgụ dị iche iche. Ọgwụ dị na ụdị atọ - 50, 850 na 1000 mg.
- Galvus dị ka akụrụngwa na-arụ ọrụ nwere vildagliptin, nke bụ analogliptin bụ analog. Usoro onodu ogwu eji eme ihe n’ime nkwadebe bu 50 mg. Usoro onodu ogwu nke metformin na mejuputara ogwu ahu bu 500, 850, na 1000 mg.
- Onglisa na ihe mejuputara ya dika ogige di aru oru nwere saxagliptin Ngwakọta a metụtara ogige nke na - egbochi ihe enzyme na - eme ka ọ dị mma. Ọgwụ dị na onunu ogwu nke 2.5 na 5 mg.
- Combogliz Prolong bụ ngwakọta nke saxagliptin na metformin. Ọgwụ a dị n'ụdị mbadamba. Ntọhapụ nke ihe ndị nọ n'ọrụ na-apụta n'ụdị oge.
- Trazhenta bụ ọgwụ hypoglycemic mere na ndabere nke linagliptin. Ngwakọta ọgwụ a nwere 5 mg nke ihe mejupụtara ya.
Ọnụ ego ọgwụ na-efu dị na mpaghara a na-ere ọgwụ ahụ na Russia. Ọnụ ego ọgwụ a bụ 843 rubles.
A kọwara ihe ọgwụgwọ ndị ọzọ enwere ike iji gwọọ ọrịa shuga na vidiyo n'isiokwu a.
